mRNA delivery enabled by metal–organic nanoparticles

• Published in: Nature communications Vol. 15; no. 1; pp. 9664 - 15
• Main Authors: Gu, Yuang, Chen, Jingqu, Wang, Zhaoran, Liu, Chang, Wang, Tianzheng, Kim, Chan-Jin, Durikova, Helena, Fernandes, Soraia, Johnson, Darryl N., De Rose, Robert, Cortez-Jugo, Christina, Caruso, Frank
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 08.11.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 13; 14; 140/58; 49; 631/61; 639/301; 639/925; 64; 692/700; Biocompatibility; Cations; Drug development; Gene expression; Genetic modification; Humanities and Social Sciences; In vivo methods and tests; Intravenous administration; Metal ions; Metals; multidisciplinary; Nanoparticles; Platforms; Polyethylene glycol; Protein composition; Robustness; Science; Science (multidisciplinary); Toxicity; Transfection; Tropism
• ISSN: 2041-1723; 2041-1723
• DOI: 10.1038/s41467-024-53969-w

mRNA therapeutics are set to revolutionize disease prevention and treatment, inspiring the development of platforms for safe and effective mRNA delivery. However, current mRNA delivery platforms face some challenges, including limited organ tropism for nonvaccine applications and inflammation induced by cationic nanoparticle components. Herein, we address these challenges through a versatile, noncationic nanoparticle platform whereby mRNA is assembled into a poly(ethylene glycol)-polyphenol network stabilized by metal ions. Screening a range of components and relative compositional ratios affords a library of stable, noncationic, and highly biocompatible metal–organic nanoparticles with robust mRNA transfection in vitro and in mice. Intravenous administration of the lead mRNA-containing metal–organic nanoparticles enables predominant protein expression and gene editing in the brain, liver, and kidney, while organ tropism is tuned by varying nanoparticle composition. This study opens an avenue for realizing metal–organic nanoparticle-enabled mRNA delivery, offering a modular approach to assembling mRNA therapeutics for health applications. Potential toxicity from cationic moieties and limited organ tropism are two challenges faced by current mRNA delivery vehicles. Here, authors develop non-cationic, highly biocompatible metal–organic nanoparticles that enable robust mRNA expression in vivo with tunable organ tropism.